logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5115.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5115.produseast1
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India | Conference Material / Slide Presentation | MSF Science Portal
Conference Material
|Slide Presentation

Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India

Mansoor H, Hirani N, Chavan VV, Joshi A, Oswal V, Sharma J, Iyer AS, England K, Ndlovu Z, Silsarma A, Isaakidis P, Morales M
Download
Similar Content
Abstract
|Abstract
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022
Loading...
Loading...
No abstract available

Countries

India

Subject Area

antibiotic resistancetuberculosisdiagnosticsgenetics & genomicsantimicrobial resistance

Languages

English
DOI
10.57740/x7k7-xj13
Published Date
11 May 2022
Conference
MSF Scientific Days International 2022
Linked Content
Conference Material
|Abstract
Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India
2022 May 11 • MSF Scientific Days International 2022